Skip to main content
XENE logo

XENE · Xenon Pharmaceuticals Inc.

Track XENE — free
$62.35 -1.88 (-2.93%) At close · Aug 14
Market Cap
$6.04B
Shares
96.84M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Ian Mortimer $9,221,712
Thomas Kelly $7,238,664
Darren Cline $4,048,214
Christopher Kenney $3,145,290
Andrea DiFabio $3,062,790
Sherry Aulin $356,453
Fiscal 2024
Executive Total
Ian Mortimer $9,795,347
Christopher Kenney $4,196,940
Sherry Aulin $4,164,888
Andrea DiFabio $4,104,490
Christopher Von Seggern $4,090,590
Fiscal 2023
Executive Total
Ian Mortimer $10,117,829
Christopher Kenney $3,578,066
Sherry Aulin $3,523,045
Christopher Von Seggern $2,764,805
Robin Sherrington $2,373,432
Andrea DiFabio $1,721,162
Fiscal 2022
Executive Total
Ian Mortimer $9,228,604
Andrea DiFabio $3,552,950
Christopher Kenney $3,263,857
Sherry Aulin $3,212,859
Christopher Von Seggern $2,681,779
Fiscal 2021
Executive Total
Simon Pimstone $4,116,416
Ian Mortimer $3,894,997
Sherry Aulin $2,008,525
Christopher Kenney $1,935,409
Fiscal 2020
Executive Total
Simon Pimstone $2,941,911
Ian Mortimer $1,783,084
Ernesto Aycardi $1,106,739
Fiscal 2019
Executive Total
Simon Pimstone $2,612,720
Ian Mortimer $1,553,382
Ernesto Aycardi $1,072,977
Fiscal 2018
Executive Total
Simon Pimstone $1,165,195
Ian Mortimer $922,681
Ernesto Aycardi $692,011
Fiscal 2017
Executive Total
Simon Pimstone $1,469,198
Corporate Secretary $944,770

Executive changes

Person Change Filed
Thomas (Tucker) Kelly Appointed 2025-10-16
Sherry Aulin Resigned 2025-07-03
Ian Mortimer Appointed 2025-07-03
Ian Mortimer Appointed 2025-07-03
Sherry Aulin Resigned 2025-02-27
Justin Gover Appointed 2023-08-08
Gillian Cannon Appointed 2023-08-08
Gary Patou Appointed 2022-06-02
Elizabeth Garofalo Appointed 2022-06-02
Patrick Machado Appointed 2022-06-02
Ian Mortimer Appointed 2022-06-02
Steven Gannon Appointed 2022-06-02
Dawn Svoronos Appointed 2022-06-02
Mohammad Azab Appointed 2022-06-02
Simon Pimstone Appointed 2022-06-02
Key facts CIK 1582313 CUSIP 98420N105 13F (30d) 307 filings 301 filers Visit website Investor relations